PMID: 8207189Apr 1, 1994Paper

Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
I I RaadG P Bodey

Abstract

In many hospitals, the only sterile precautions used during the insertion of a nontunneled central venous catheter are sterile gloves and small sterile drapes. We investigated whether the use of maximal sterile barrier (consisting of mask, cap, sterile gloves, gown, and large drape) would lower the risk of acquiring catheter-related infections. Prospective randomized trial. A 500-bed cancer referral center. We randomized patients to have their nontunneled central catheter inserted under maximal sterile barrier precautions or control precautions (sterile gloves and small drape only). All patients were followed for 3 months postinsertion or until the catheter was removed, whichever came first. Catheter-related infections were diagnosed by quantitative catheter cultures and/or simultaneous quantitative blood cultures. The 176 patients whose catheters were inserted by using maximal sterile barrier precautions were comparable to the 167 control patients in underlying disease, degree of immuno-suppression, therapeutic interventions, and catheter risk factors for infections (duration and site of catheterization, number of catheter lumen, catheter insertion difficulty, reason for catheter removal). There were a total of four catheter i...Continue Reading

Citations

Apr 28, 2004·Archives of Internal Medicine·Barbara W Trautner, Rabih O Darouiche
Jun 1, 1996·Intensive Care Medicine·A Bach
Jan 5, 2002·Indian Journal of Pediatrics·R LodhaM Natchu
Apr 26, 2006·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Clinton J Torok-BothPeter G Brindley
Apr 21, 2005·Der Internist·A F Widmer
May 23, 2012·Intensive Care Medicine·Massimo LampertiSusan T Verghese
Sep 29, 1999·Cardiovascular and Interventional Radiology·J Namyslowski, N H Patel
Jul 17, 2008·Annals of Hematology·Hans-Heinrich WolfUNKNOWN Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
May 2, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Eva JohanssonMagnus Björkholm
Jun 22, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I RaadK Rolston
Nov 28, 2001·Current Infectious Disease Reports·Nasia SafdarDennis G. Maki
May 7, 2005·American Journal of Infection Control·Linda McKibbenUNKNOWN Heathcare Infection Control Practices Advisory Committee
Feb 6, 2004·Best Practice & Research. Clinical Anaesthesiology·Bernard CanaudJean-Jacques Béraud
Mar 9, 2004·The Journal of Hospital Infection·A Boulamery-VellyB La Scola
Jan 15, 2000·AORN Journal·P C Seifert
Aug 1, 1996·The American Journal of Cardiology·C OpasichL Tavazzi
Jun 20, 2003·Lancet·Jean-Louis Vincent
Aug 1, 1995·Seminars in Oncology Nursing·K A Rumsey, D K Richardson
Mar 1, 1996·Nutrition·K A Adal, B M Farr
Feb 13, 2003·Journal of Vascular and Interventional Radiology : JVIR·Donald L Miller, Naomi P O'Grady
Jun 27, 2003·The New England Journal of Medicine·David A Berlin
Mar 21, 2003·The New England Journal of Medicine·David C McGee, Michael K Gould
Oct 12, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B M Farr
May 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher J Crnich, Dennis G Maki
Oct 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Bart J A RijndersWilly E Peetermans
Dec 4, 2002·American Journal of Infection Control·Naomi P O'gradyUNKNOWN Healthcare Infection Control Practices Advisory Committee
Mar 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Bart J A RijndersWilly E Peetermans
Sep 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nathorn ChaiyakunaprukSanjay Saint
Nov 17, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kent K HuSanjay Saint
Jun 30, 2010·Surgical Infections·Richard D Collage, Matthew R Rosengart
Jan 6, 2011·British Journal of Anaesthesia·F J BeldaUNKNOWN PICS Investigators Group
Jan 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of Americaa
Jan 25, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of America
Apr 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Naomi P O'GradyUNKNOWN Healthcare Infection Control Practices Advisory Committee (HICPAC) (Appendix 1)
Apr 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Naomi P O'GradyUNKNOWN Healthcare Infection Control Practices Advisory Committee (HICPAC)

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.